The President’s new drug tariff plan gives generic drug importers a two-year reprieve—no tariffs until August 2026—but then slams the brakes hard: 100% tariffs in 2028, jumping to 200% by 2029. The goal? Force manufacturers to bring production back to the U.S., create jobs, and reshape the pharmaceutical supply chain—while leaving branded drugs untouched. It’s a bold carrot-and-stick strategy, already drawing deals from major drugmakers to avoid the steep penalties.
Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN: advertise@thednn.ai
This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai.
Podden och tillhörande omslagsbild på den här sidan tillhör
The Daily News Now!. Innehållet i podden är skapat av The Daily News Now! och inte av,
eller tillsammans med, Poddtoppen.
